NM memorial calling for study of forced sterilization against women of color advances
By Leah Romero,
SourceNM
| 02. 06. 2026
An historical poster from 1977 created by Rachael Romero for the
Wilfred Owen Brigade in San Francisco, California. (Library of Congress)
Members of the New Mexico Legislature’s House Government, Elections and Indian Affairs Committee advanced a memorial Friday that calls for a “comprehensive” study of the scope and impact of forced sterilization of Indigenous women and women of color in New Mexico.
House Memorial 32 requests the New Mexico Indian Affairs Department and the New Mexico Commission on the Status of Women identify all cases of forced or coerced sterilization that have occurred in the state and gather survivor testimony. The memorial requests that the agencies evaluate the availability of reproductive health services for women of color and recommend actions the state can take to prevent future forced sterilization practices.
The legislation also requests that the study explore creating a reproductive sovereignty program “focused on culturally grounded health, education and healing services,” developing a public memorial and having the state formally acknowledge the “inhumanity of the grievous policy” of forced sterilization.
The memorial states that the study must be completed...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...